Wanbury Limited — Investor Relations & Filings
Filings indexed
502
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
IN
India
Listing
BSE.NS
WANBURY
Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| The Board Meeting to be held on 14/05/2026 has been revised to 29/05/2026 The Board Meeting to be held on 14/05/2026 has been revised to 29/05/2026 | 2026-05-12 | English | |
| Press Release | 2026-04-28 | English | |
| General Updates | 2026-04-24 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-26 | English | |
| Press Release | 2026-03-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45250793 | The Board Meeting to be held on 14/05/2026 has been revised to 29/05/2026 The Board Meeting to be held on 14/05/2026 has been revised to 29/05/2026 | 2026-05-12 | English | ||
| 42201015 | Press Release | 2026-04-28 | English | ||
| 42228861 | General Updates | 2026-04-24 | English | ||
| 42204885 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42168041 | Trading Window | 2026-03-26 | English | ||
| 42200164 | Press Release | 2026-03-24 | English | ||
| 42168075 | Press Release | 2026-03-12 | English | ||
| 42168231 | Reply to Clarification- Financial results | 2026-03-05 | English | ||
| 42263407 | Investor Presentation | 2026-02-09 | English | ||
| 42288903 | Press Release | 2026-02-06 | English | ||
| 42164961 | ESOP/ESOS/ESPS | 2026-02-05 | English | ||
| 42165139 | ESOP/ESOS/ESPS | 2026-02-05 | English | ||
| 42165443 | Outcome of Board Meeting | 2026-02-05 | English | ||
| 42165557 | Outcome of Board Meeting | 2026-02-05 | English | ||
| 42225323 | Press Release | 2026-02-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Wanbury Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60248/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60248 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60248 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60248 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60248}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Wanbury Limited (id: 60248)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.